Literature DB >> 17467962

Protective effects of hepatocellular canalicular conjugate export pump (Mrp2) on sodium arsenite-induced hepatic dysfunction in rats.

Guo-Xing Li1, Qiu-Ling Pei, Yi Gao, Ke-Ming Liu, Ji-Sheng Nie, Guang Han, Yu-Lan Qiu, Wen-Ping Zhang.   

Abstract

Arsenic is a double-edged sword to human health. The excretion of various organic anions into bile is mediated by an adenosine triphosphate-dependent conjugate export pump, which has been identified as the canalicular isoform of the multidrug resistance protein 2 (Mrp2). It has been proved that Mrp2 can transport arsenite in vitro, but its effects in vivo are not clear. The aim of this study was to investigate whether Mrp2 plays a role in exportation of arsenic in vivo and its protective effects on liver function. Mrp2 protein level in rat liver was determined by Western blot analysis. Total arsenic concentrations in whole blood and bile were measured using hydride generation atomic absorption spectrometry. Alanine aminotransferase (ALT) activity, aspartate aminotransferase activity (AST), glutathione peroxidase (GSH-PX) activity, malon dialdehyde (MDA) and total bilirubin were measured by biochemical assays. The morphological changes were observed by electron microscopy. Total arsenic levels in blood and bile of arsenite-treated rats were significantly higher than those of control rats (P<0.05) at all three different time points. The overexpression of Mrp2 was 36.61%, 32.36% and 12.73% at 2, 4 and 6 weeks, respectively (percentage of controls, P<0.05), which was significantly higher than controls. A positive correlation between Mrp2 expression level and total arsenic concentration in bile indicated that Mrp2 accelerated the transport of arsenic. Electron microscopy showed that microvilli of bile canaliculi became swollen and sparse. ALT and AST activities in serum were markedly raised at 6 weeks. MDA level in serum increased (P<0.05) and GSH-PX activity in serum decreased except for 2 weeks. Damage of liver function became worse following decreased expression of Mrp2. In conclusion, overexpression of Mrp2 may explain increased biliary excretion of arsenic and it may protect liver function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467962     DOI: 10.1016/j.etp.2007.02.001

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  4 in total

1.  Mechanisms pertaining to arsenic toxicity.

Authors:  Amrit Pal Singh; Rajesh Kumar Goel; Tajpreet Kaur
Journal:  Toxicol Int       Date:  2011-07

Review 2.  Metabolism, toxicity and anticancer activities of arsenic compounds.

Authors:  Islam Khairul; Qian Qian Wang; Yu Han Jiang; Chao Wang; Hua Naranmandura
Journal:  Oncotarget       Date:  2017-04-04

3.  Arsenic-based antineoplastic drugs and their mechanisms of action.

Authors:  Stephen John Ralph
Journal:  Met Based Drugs       Date:  2008

4.  Physiologically Based Pharmacokinetic Model for Prediction of Leflunomide and Teriflunomide: Should Consideration Be Given to Cannalicular Efflux Transporters?

Authors:  N R Srinivas
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.